Intravenous sedation for adults with profound acquired brain injury undergoing dental treatment - a seven-year service evaluation
- PMID: 39737897
- PMCID: PMC11686102
- DOI: 10.1038/s41405-024-00289-2
Intravenous sedation for adults with profound acquired brain injury undergoing dental treatment - a seven-year service evaluation
Abstract
Background: Dental treatment may not be possible for patients with a profound acquired brain injury without pharmacological support. Intravenous (IV) sedation with midazolam is a widely accepted, safe, and effective mode of treatment for people with a disability, but there is limited evidence in this patient cohort.
Aims: This evaluation aimed to review the IV sedation service for patients with profound acquired brain injury within the dental department at the Royal Hospital for Neuro-disability.
Method: This study was a retrospective service evaluation of IV sedation for dental treatment over seven years. Descriptive statistics are presented.
Results: In total, 303 episodes of sedation were undertaken at the Royal Hospital of Neurodisability over seven years. Ninety-two percent were graded with an American Society of Anaesthesiologists (ASA) grade 3, and one-third had a history of stroke. 91% had treatment completed successfully. Complications occurred in 7.9% of cases, but all were minor, with no resulting patient harm (e.g. a transient drop in oxygen saturation).
Conclusion: Dentist-led IV sedation with midazolam is safe and effective for dental treatment for patients with a profound acquired brain injury in a specialised setting with experienced clinicians.
© 2024. Crown.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethical approval: Ethical approval was not required for this study based on the Health Research Authority toolkit: this is a retrospective service evaluation, the participants were not randomised, and there was no change to usual clinical practice.
Similar articles
-
Effectiveness and safety of dentist-led conscious sedation using fentanyl with midazolam in dentistry: a five-year retrospective service evaluation.Br Dent J. 2023 Jun 7:1-6. doi: 10.1038/s41415-023-5889-3. Online ahead of print. Br Dent J. 2023. PMID: 37286715 Free PMC article.
-
Complications associated with intravenous midazolam and fentanyl sedation in patients undergoing minor oral surgery.J Dent Anesth Pain Med. 2017 Sep;17(3):199-204. doi: 10.17245/jdapm.2017.17.3.199. Epub 2017 Sep 25. J Dent Anesth Pain Med. 2017. PMID: 29090250 Free PMC article.
-
Effectiveness and acceptability of intravenous sedation in child and adolescent dental patients: report of a case series at King's College Hospital, London.Br Dent J. 2011 Jun 24;210(12):567-72. doi: 10.1038/sj.bdj.2011.482. Br Dent J. 2011. PMID: 21701471
-
Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disability.Br Dent J. 2008 Jul 26;205(2):E3; discussion 84-5. doi: 10.1038/sj.bdj.2008.521. Epub 2008 Jun 13. Br Dent J. 2008. PMID: 18545267
-
Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation.Drugs. 2011 Jul 30;71(11):1481-501. doi: 10.2165/11207190-000000000-00000. Drugs. 2011. PMID: 21812509 Review.
References
-
- Shehabi Z, Flood C, Matthew L. Midazolam use for dental conscious sedation: how safe are we? Br Dent J. 2018;224:98–104. - PubMed
-
- Ransford NJ, Manley MCG, Lewis DA, Thompson SA, Wray LJ, Boyle CA, et al. Intranasal/intravenous sedation for the dental care of adults with severe disabilities: a multicentre prospective audit. Br Dent J. 2010;208:565–9. - PubMed
-
- Gu Jwen, Yang T, Kuang Yqin, Huang Hdong, Kong B, Shu Hfeng, et al. Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: a meta-analysis. J Crit Care. 2014;29:287–90. - PubMed
LinkOut - more resources
Full Text Sources